Oncotarget

Research Papers:

Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models

Kei Kawaguchi, Qinghong Han, Shukuan Li, Yuying Tan, Kentaro Igarashi, Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Bartosz Bartosz, Scott D. Nelson, Tara A. Russell, Sarah M. Dry, Yunfeng Li, Arun S. Singh, Mark A. Eckardt, Michiaki Unno, Fritz C. Eilber and Robert M. Hoffman _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:11119-11125. https://doi.org/10.18632/oncotarget.24264

Metrics: PDF 878 views  |   HTML 1392 views  |   ?  


Abstract

Kei Kawaguchi1,2,3, Qinghong Han1, Shukuan Li1, Yuying Tan1, Kentaro Igarashi1,2, Kentaro Miyake1,2, Tasuku Kiyuna1,2, Masuyo Miyake1,2, Bartosz Chemielwski4, Scott D. Nelson5, Tara A. Russell6, Sarah M. Dry5, Yunfeng Li5, Arun S. Singh4, Mark A. Eckardt7, Michiaki Unno3, Fritz C. Eilber6 and Robert M. Hoffman1,2

1AntiCancer, Inc., San Diego, CA, USA

2Department of Surgery, University of California, San Diego, CA, USA

3Department of Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan

4Division of Hematology-Oncology, University of California, Los Angeles, CA, USA

5Department of Pathology, University of California, Los Angeles, CA, USA

6Division of Surgical Oncology, University of California, Los Angeles, CA, USA

7Department of Surgery, Yale School of Medicine, New Haven, CT, USA

Correspondence to:

Robert M. Hoffman, email: all@anticancer.com

Fritz C. Eilber, email: fceilber@mednet.ucla.edu

Michiaki Unno, email: m_unno@surg1.med.tohoku.ac.jp

Keywords: recombinant methionine (rMETase); methionine dependence; tumor methionine; pancreatic cancer; melanoma

Received: December 23, 2017     Accepted: January 09, 2018     Published: January 17, 2018

ABSTRACT

An excessive requirement for methionine (MET) for growth, termed MET dependence, appears to be a general metabolic defect in cancer. We have previously shown that cancer-cell growth can be selectively arrested by MET restriction such as with recombinant methioninase (rMETase). In the present study, we utilized patient-derived orthotopic xenograft (PDOX) nude mouse models with pancreatic cancer or melanoma to determine the relationship between intra-tumor MET level and tumor size. After the tumors grew to 100 mm3, the PDOX nude mice were divided into two groups: untreated control and treated with rMETase (100 units, i.p., 14 consecutive days). On day 14 from initiation of treatment, intra-tumor MET levels were measured and found to highly correlate with tumor volume, both in the pancreatic cancer PDOX (p<0.0001, R2=0.89016) and melanoma PDOX (p<0.0001, R2=0.88114). Tumors with low concentration of MET were smaller. The present results demonstrates that patient tumors are highly dependent on MET for growth and that rMETase effectively lowers tumor MET.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 24264